BRONCHIAL CARCINOID

Clinical trials for BRONCHIAL CARCINOID explained in plain language.

Never miss a new study

Get alerted when new BRONCHIAL CARCINOID trials appear

Sign up with your email to follow new studies for BRONCHIAL CARCINOID, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Radioactive drug targets hard-to-treat neuroendocrine tumors in early trial

Disease control Not yet recruiting

This phase 1 trial tests a radioactive drug called 211At-MABG in 16 adults with advanced neuroendocrine cancers, including pheochromocytoma and paraganglioma. The drug delivers radiation directly to cancer cells that show up on a special scan. The main goal is to see if the treat…

Matched conditions: BRONCHIAL CARCINOID

Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Disease control

Last updated Jun 23, 2026 11:59 UTC

BRONCHIAL CARCINOID

Get alerted when new BRONCHIAL CARCINOID trials appear

Radioactive drug targets hard-to-treat neuroendocrine tumors in early trial